======= GALNT2 ======= == Gene Information == * **Official Symbol**: GALNT2 * **Official Name**: polypeptide N-acetylgalactosaminyltransferase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2590|2590]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q10471|Q10471]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GALNT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALNT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602274|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the glycosyltransferase 2 protein family. Members of this family initiate mucin-type O-glycoslation of peptides in the Golgi apparatus. The encoded protein may be involved in O-linked glycosylation of the immunoglobulin A1 hinge region. This gene may influence triglyceride levels, and may be involved Type 2 diabetes, as well as several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]. * **UniProt Summary**: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D- galactosamine residue to a serine or threonine residue on the protein receptor. Has a broad spectrum of substrates for peptides such as EA2, Muc5AC, Muc1a, Muc1b. Probably involved in O-linked glycosylation of the immunoglobulin A1 (IgA1) hinge region. {ECO:0000269|PubMed:12438318, ECO:0000269|PubMed:16434399, ECO:0000269|PubMed:7592619, ECO:0000269|PubMed:9295285}. |Ricin B lectin| |Glycos transf 2| |immunoglobulin biosynthetic process| |protein O-linked glycosylation via threonine| |protein O-linked glycosylation via serine| |polypeptide N-acetylgalactosaminyltransferase activity| |Golgi stack| |O-glycan processing| |manganese ion binding| |integral component of Golgi membrane| |peptidyl-threonine modification| |Golgi cisterna membrane| |protein O-linked glycosylation| |immunoglobulin production| |carbohydrate binding| |production of molecular mediator of immune response| |peptidyl-serine modification| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |carbohydrate derivative biosynthetic process| |Golgi membrane| |perinuclear region of cytoplasm| |peptidyl-amino acid modification| |endoplasmic reticulum membrane| |Golgi apparatus| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |extracellular region| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.17| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.82| |[[:results:exp219|A-395N 10μM R05 exp219]]|1.71| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.79| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.01| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|3.84| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9996 * **Expression level (log2 read counts)**: 9.32 {{:chemogenomics:nalm6 dist.png?nolink |}}